| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | methylated histone binding | 7.42e-05 | 86 | 52 | 4 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 8.11e-05 | 88 | 52 | 4 | GO:0140034 | |
| GeneOntologyMolecularFunction | XMP 5'-nucleosidase activity | 1.84e-04 | 8 | 52 | 2 | GO:0106411 | |
| GeneOntologyMolecularFunction | 5'-nucleotidase activity | 6.83e-04 | 15 | 52 | 2 | GO:0008253 | |
| GeneOntologyMolecularFunction | nucleotidase activity | 9.91e-04 | 18 | 52 | 2 | GO:0008252 | |
| GeneOntologyCellularComponent | intraciliary transport particle A | 1.68e-04 | 8 | 52 | 2 | GO:0030991 | |
| Domain | Spin-Ssty | 2.67e-10 | 5 | 52 | 4 | PF02513 | |
| Domain | SPIN/Ssty | 2.67e-10 | 5 | 52 | 4 | IPR003671 | |
| Domain | TPR-like_helical_dom | 3.57e-06 | 233 | 52 | 7 | IPR011990 | |
| Domain | TPR_1 | 5.05e-06 | 90 | 52 | 5 | PF00515 | |
| Domain | TPR_1 | 5.05e-06 | 90 | 52 | 5 | IPR001440 | |
| Domain | SPIN-2 | 7.60e-06 | 2 | 52 | 2 | IPR029564 | |
| Domain | 5-nucleotidase | 2.28e-05 | 3 | 52 | 2 | PF06189 | |
| Domain | 5-nucleotidase | 2.28e-05 | 3 | 52 | 2 | IPR010394 | |
| Domain | - | 2.29e-05 | 207 | 52 | 6 | 1.25.40.10 | |
| Domain | TPR | 2.91e-05 | 129 | 52 | 5 | SM00028 | |
| Domain | TPR_repeat | 3.37e-05 | 133 | 52 | 5 | IPR019734 | |
| Domain | TPR-contain_dom | 5.99e-05 | 150 | 52 | 5 | IPR013026 | |
| Domain | TPR_REGION | 9.41e-05 | 165 | 52 | 5 | PS50293 | |
| Domain | TPR | 9.41e-05 | 165 | 52 | 5 | PS50005 | |
| Domain | Integrin_bsu_cyt_dom | 1.13e-04 | 6 | 52 | 2 | IPR014836 | |
| Domain | Integrin_b_cyt | 1.13e-04 | 6 | 52 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 1.13e-04 | 6 | 52 | 2 | PF08725 | |
| Domain | Integrin_bsu_tail | 1.58e-04 | 7 | 52 | 2 | IPR012896 | |
| Domain | Integrin_B_tail | 1.58e-04 | 7 | 52 | 2 | SM01242 | |
| Domain | Integrin_B_tail | 1.58e-04 | 7 | 52 | 2 | PF07965 | |
| Domain | Integrin_beta | 2.11e-04 | 8 | 52 | 2 | PF00362 | |
| Domain | INB | 2.11e-04 | 8 | 52 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 2.11e-04 | 8 | 52 | 2 | IPR002369 | |
| Domain | PSI | 2.49e-04 | 44 | 52 | 3 | IPR016201 | |
| Domain | Integrin_bsu | 2.70e-04 | 9 | 52 | 2 | IPR015812 | |
| Domain | Integin_beta_N | 2.70e-04 | 9 | 52 | 2 | IPR033760 | |
| Domain | INTEGRIN_BETA | 2.70e-04 | 9 | 52 | 2 | PS00243 | |
| Domain | PSI_integrin | 2.70e-04 | 9 | 52 | 2 | PF17205 | |
| Domain | PSI | 2.84e-04 | 46 | 52 | 3 | SM00423 | |
| Domain | TPR_8 | 4.32e-04 | 53 | 52 | 3 | PF13181 | |
| Domain | EF_Hand_1_Ca_BS | 1.42e-03 | 175 | 52 | 4 | IPR018247 | |
| Domain | Integrin_dom | 2.19e-03 | 25 | 52 | 2 | IPR032695 | |
| Domain | Kinase-like_dom | 3.81e-03 | 542 | 52 | 6 | IPR011009 | |
| Domain | EF_hand_dom | 3.94e-03 | 232 | 52 | 4 | IPR002048 | |
| Domain | TPR_2 | 8.55e-03 | 50 | 52 | 2 | PF07719 | |
| Pubmed | A transcriptional coregulator, SPIN·DOC, attenuates the coactivator activity of Spindlin1. | 6.65e-11 | 6 | 52 | 4 | 29061846 | |
| Pubmed | Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression. | 2.19e-06 | 2 | 52 | 2 | 12145692 | |
| Pubmed | Life extension factor klotho prevents mortality and enhances cognition in hAPP transgenic mice. | 6.57e-06 | 3 | 52 | 2 | 25673831 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 11690631 | ||
| Pubmed | Rack1, a receptor for activated protein kinase C, interacts with integrin beta subunit. | 2.19e-05 | 5 | 52 | 2 | 9442085 | |
| Pubmed | 2.20e-05 | 225 | 52 | 5 | 12168954 | ||
| Pubmed | HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. | 3.28e-05 | 6 | 52 | 2 | 8757599 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DST TTC28 SSX2IP ATG2B TACC2 RABGAP1 PLXNB2 IFIT1 GRSF1 EXOC4 | 6.38e-05 | 1496 | 52 | 10 | 32877691 |
| Pubmed | 7.86e-05 | 151 | 52 | 4 | 17043677 | ||
| Pubmed | 9.79e-05 | 10 | 52 | 2 | 32994168 | ||
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 19693543 | ||
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 12606711 | ||
| Pubmed | 1.97e-04 | 14 | 52 | 2 | 27650319 | ||
| Pubmed | 2.74e-04 | 209 | 52 | 4 | 36779422 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.82e-04 | 861 | 52 | 7 | 36931259 | |
| Pubmed | 4.00e-04 | 418 | 52 | 5 | 34709266 | ||
| Pubmed | 4.08e-04 | 650 | 52 | 6 | 38777146 | ||
| Pubmed | 4.13e-04 | 421 | 52 | 5 | 36976175 | ||
| Pubmed | 6.40e-04 | 708 | 52 | 6 | 39231216 | ||
| Pubmed | 6.61e-04 | 467 | 52 | 5 | 30194290 | ||
| Pubmed | 6.96e-04 | 26 | 52 | 2 | 26857994 | ||
| Pubmed | Same but different - Molecular comparison of human KTI12 and PSTK. | 7.51e-04 | 27 | 52 | 2 | 33417976 | |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 7.51e-04 | 27 | 52 | 2 | 31541017 | |
| Pubmed | Chromatin regulation by BAF170 controls cerebral cortical size and thickness. | 8.08e-04 | 28 | 52 | 2 | 23643363 | |
| Pubmed | Regulation of archicortical arealization by the transcription factor Zbtb20. | 8.08e-04 | 28 | 52 | 2 | 22689450 | |
| Pubmed | 1.04e-03 | 777 | 52 | 6 | 35844135 | ||
| Pubmed | 1.06e-03 | 32 | 52 | 2 | 23154389 | ||
| Pubmed | Zbtb20 is essential for the specification of CA1 field identity in the developing hippocampus. | 1.06e-03 | 32 | 52 | 2 | 20308569 | |
| Pubmed | 1.16e-03 | 794 | 52 | 6 | 11076863 | ||
| Interaction | CDY2A interactions | 1.94e-07 | 21 | 50 | 4 | int:CDY2A | |
| Interaction | DEFB107A interactions | 4.04e-06 | 13 | 50 | 3 | int:DEFB107A | |
| Cytoband | Xp11.1 | 7.54e-06 | 4 | 52 | 2 | Xp11.1 | |
| Cytoband | 3p22.2 | 3.42e-04 | 24 | 52 | 2 | 3p22.2 | |
| GeneFamily | Tudor domain containing|Spindlin family | 1.03e-10 | 5 | 40 | 4 | 1089 | |
| GeneFamily | Tudor domain containing | 1.29e-06 | 37 | 40 | 4 | 780 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.25e-06 | 115 | 40 | 5 | 769 | |
| GeneFamily | CD molecules|5'-nucleotidases | 9.95e-05 | 7 | 40 | 2 | 1042 | |
| GeneFamily | CD molecules|Integrin beta subunits | 1.70e-04 | 9 | 40 | 2 | 1159 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 1.28e-03 | 24 | 40 | 2 | 615 | |
| GeneFamily | EF-hand domain containing | 1.36e-03 | 219 | 40 | 4 | 863 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_500 | 4.13e-06 | 276 | 51 | 7 | gudmap_kidney_P1_CapMes_Crym_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_500 | 6.24e-06 | 294 | 51 | 7 | gudmap_kidney_P0_CapMes_Crym_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_1000 | 1.88e-05 | 639 | 51 | 9 | gudmap_kidney_P0_CapMes_Crym_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_100 | 6.20e-05 | 89 | 51 | 4 | gudmap_kidney_P3_CapMes_Crym_100 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | CUX2 TTC28 SPIN2A WDR35 NBEA PLCH1 SPIN2B RNF145 KCNIP1 PHF10 NAA16 | 1.46e-04 | 1245 | 51 | 11 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.06e-07 | 195 | 52 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.06e-07 | 195 | 52 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.21e-06 | 160 | 52 | 5 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.12e-06 | 194 | 52 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.20e-06 | 195 | 52 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 3.28e-06 | 196 | 52 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.36e-06 | 197 | 52 | 5 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 3.45e-06 | 198 | 52 | 5 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.62e-06 | 200 | 52 | 5 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.62e-06 | 200 | 52 | 5 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.62e-06 | 200 | 52 | 5 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.43e-05 | 126 | 52 | 4 | 94bd9cfe982b41a3114885173eab55feb0fbbbae | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-05 | 152 | 52 | 4 | 5adcdf93fd3ca066402aaaf308c363e4648f871d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.14e-05 | 154 | 52 | 4 | a2adaa4a6cd8708cd579b8efbeb4ff2131c5482e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.23e-05 | 155 | 52 | 4 | 5c7b68b59244525e3714806c205a57a2daebf423 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.74e-05 | 161 | 52 | 4 | bf70be1de418615b5442ec684552551edaf1f072 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.74e-05 | 161 | 52 | 4 | 3b5d7a3dab479c6959a428f3954dedd989900276 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.83e-05 | 162 | 52 | 4 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.52e-05 | 169 | 52 | 4 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.95e-05 | 173 | 52 | 4 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | B_cells-pDCs|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.29e-05 | 176 | 52 | 4 | ce757de9e09a225f3f96433f103f43619b0e0dda | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 177 | 52 | 4 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.29e-05 | 184 | 52 | 4 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.29e-05 | 184 | 52 | 4 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.69e-05 | 187 | 52 | 4 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 6.83e-05 | 188 | 52 | 4 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.12e-05 | 190 | 52 | 4 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | (01)_Dendritic_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 7.27e-05 | 191 | 52 | 4 | 1f4c8078e1a6cd14937c714330af608caced2acf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.27e-05 | 191 | 52 | 4 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.27e-05 | 191 | 52 | 4 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 7.41e-05 | 192 | 52 | 4 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 7.41e-05 | 192 | 52 | 4 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 7.41e-05 | 192 | 52 | 4 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 7.41e-05 | 192 | 52 | 4 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.56e-05 | 193 | 52 | 4 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.56e-05 | 193 | 52 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.56e-05 | 193 | 52 | 4 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 7.56e-05 | 193 | 52 | 4 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | Control-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 7.72e-05 | 194 | 52 | 4 | 5f95a5a35f73222dbe2ca52cc580f4774f641403 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.72e-05 | 194 | 52 | 4 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 7.72e-05 | 194 | 52 | 4 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.72e-05 | 194 | 52 | 4 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-05 | 195 | 52 | 4 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-05 | 195 | 52 | 4 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-05 | 195 | 52 | 4 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.87e-05 | 195 | 52 | 4 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 7.87e-05 | 195 | 52 | 4 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 8.03e-05 | 196 | 52 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 8.03e-05 | 196 | 52 | 4 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.03e-05 | 196 | 52 | 4 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.19e-05 | 197 | 52 | 4 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.19e-05 | 197 | 52 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.19e-05 | 197 | 52 | 4 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.19e-05 | 197 | 52 | 4 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | (5)_Dendritic_cell-(54)_pDC|(5)_Dendritic_cell / shred on Cell_type and subtype | 8.35e-05 | 198 | 52 | 4 | fc6c6b60dddd7f2f997af0f87fae33f1c23f34a8 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.35e-05 | 198 | 52 | 4 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-05 | 199 | 52 | 4 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-05 | 199 | 52 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| Drug | lithium indium | 5.12e-06 | 2 | 52 | 2 | CID011116062 | |
| Drug | scandium phosphate | 5.12e-06 | 2 | 52 | 2 | CID006365269 | |
| Drug | rubidium nitrate | 5.12e-06 | 2 | 52 | 2 | CID000025731 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 8.98e-05 | 49 | 52 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | p-tau:beta-amyloid 1-42 ratio measurement | 5.11e-04 | 19 | 52 | 2 | EFO_0007709 | |
| Disease | Infiltrating duct carcinoma of female breast | 6.26e-04 | 21 | 52 | 2 | C3165106 | |
| Disease | pulse pressure measurement | 6.63e-04 | 1392 | 52 | 9 | EFO_0005763 | |
| Disease | breast cancer, COVID-19 | 6.88e-04 | 22 | 52 | 2 | MONDO_0007254, MONDO_0100096 | |
| Disease | cancer (implicated_via_orthology) | 1.28e-03 | 268 | 52 | 4 | DOID:162 (implicated_via_orthology) | |
| Disease | ascending aortic diameter | 1.95e-03 | 140 | 52 | 3 | EFO_0021787 | |
| Disease | diverticulitis | 1.95e-03 | 37 | 52 | 2 | EFO_1001460 | |
| Disease | Microcalcification | 2.51e-03 | 42 | 52 | 2 | C0521174 | |
| Disease | Calcinosis | 2.51e-03 | 42 | 52 | 2 | C0006663 | |
| Disease | Tumoral calcinosis | 2.51e-03 | 42 | 52 | 2 | C0263628 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.76e-03 | 801 | 52 | 6 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | Gastric Adenocarcinoma | 2.87e-03 | 45 | 52 | 2 | C0278701 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IYEQEGLEKYMEYQL | 326 | Q96P26 | |
| IERERDMEIAEYYGY | 906 | A6NCI8 | |
| YTEQGVEEYVRYQLE | 71 | Q9BXI3 | |
| NEDEMYKILLNDYEY | 251 | Q9Y2D8 | |
| EQYELYMYREVDTLE | 886 | O14529 | |
| EDEYRIQMELNRYYL | 361 | Q96BY7 | |
| YMGQRYVEVYEINNE | 216 | Q12849 | |
| YQLERLMQEYIPDLY | 696 | Q9Y3P9 | |
| NGIILDYEIRYYEKE | 461 | P54762 | |
| LYVEEQEYLQAYEDV | 11 | Q03001 | |
| YETDMEIYLILEYVQ | 421 | Q9C098 | |
| REDPNYYSYLEMDLQ | 251 | O15031 | |
| LAQYMEIVANEYLGY | 161 | Q6ZWH5 | |
| DYEYSELILYQNQVM | 186 | Q6N069 | |
| RQVEDYPVDLYYLMD | 131 | P18084 | |
| YYQYQRDKIEDELEM | 26 | Q9NZI2 | |
| YYLQLEDDIIAKEMY | 251 | A6NG13 | |
| EELDYYLYGQQRMEI | 171 | Q9NQX0 | |
| EYYMLQEQVSEYLGV | 86 | Q8WUB8 | |
| LEQQDGMDRYLIYVD | 676 | P05107 | |
| MVDYYEVLGLQRYAS | 1 | Q7Z6W7 | |
| RQYYEMLYNTADELL | 896 | Q96A65 | |
| ELESYAYNEDDLMLY | 201 | A8MPY1 | |
| YYTGYTENEVLEVMQ | 331 | O95067 | |
| NYIQEILRNYMYEDF | 2231 | Q8WXX0 | |
| VYKLEGNMNEALEYY | 446 | P09914 | |
| AEDDQLRVYYMQNYI | 881 | Q9UEF7 | |
| EEVMQKYIRYAVQYD | 261 | Q9NX74 | |
| IMNLQYTEANRYDYV | 481 | Q13255 | |
| MLLCYEDEGVYVNTY | 1226 | Q8N4C8 | |
| DVYLGVYLMNQYLET | 26 | Q8N4H0 | |
| YMPLRDDYEIEYDQD | 166 | Q86TJ2 | |
| EYLAKMYEEYQRQEE | 956 | Q8NFP9 | |
| YLENLEKLMYNAYEG | 986 | Q96Q15 | |
| VLYMYQLLDDYKEGD | 171 | Q99865 | |
| DELEELMCYYQDRGY | 1281 | P53675 | |
| LMCYYQDRGYFEELI | 1286 | P53675 | |
| QYEQTLMYGRYTQDL | 16 | P51788 | |
| PEAVQILYQRMRYEY | 331 | Q9Y2C2 | |
| LYMYQLLDDYKEGDL | 176 | Q9Y657 | |
| VLYMYQLLDDYKDGD | 171 | Q5JUX0 | |
| VLYMYQLLDDYKEGD | 171 | Q9BPZ2 | |
| ELDYRNSYEIEYMEK | 2516 | O95359 | |
| YLMAQVRYYSELENA | 506 | Q8NDW8 | |
| EVYQDMDQPLCNYYI | 296 | Q4KWH8 | |
| QEMEDDYDYYGQQRV | 331 | Q9HC78 | |
| YYEQYLRLAPDLQDM | 616 | Q96AY4 | |
| EYKRYLEMLLEYLQD | 181 | Q12874 | |
| ILLQEYIMRDYGFVY | 156 | Q96PF1 | |
| RLAECYYMLEDYEGL | 831 | Q9P2L0 | |
| YYMLEDYEGLENLAI | 836 | Q9P2L0 | |
| NMDDVIYYVNGTYRL | 446 | Q96MT1 | |
| QVYYYMGVDAVQELL | 391 | Q5TAA0 | |
| LSEHYEQMEYLGRYI | 171 | Q2WGJ8 |